A prospective randomized controlled study of the prevention of cytomegalovirus infection in severe aplastic anemia by intensive immunosuppression combined with TPO receptor agonist (ChiCTR) - Aug 7, 2025 - P4 | N=100 | Recruiting | Sponsor: Suzhou Hongci Blood Disease Hospital; Suzhou Hongci Blood Disease Hospital
New P4 trial • Anemia • Aplastic Anemia • Cytomegalovirus Infection • Hematological Disorders • Infectious Disease
|